Related Experiment Videos
[Cost/benefit relations in heart transplantation]
H H Scheld1, M C Deng, D Hammel
1Klinik und Poliklinik für Thorax-, Herz- und Gefässchirurgie, Westfälische Wilhelms-Universität, Münster.
Zeitschrift Fur Kardiologie
|January 1, 1994
Summary
Cardiac transplantation is costly, with an estimated 55,000 DM per year of life gained. To optimize outcomes and manage healthcare costs, specialized centers, multicenter trials, and societal discussion on resource allocation are crucial.
Area of Science:
- Cardiology
- Health Economics
- Transplantation Medicine
Context:
- The increasing use of cardiac transplantation and mechanical/antiarrhythmic bridging necessitates an economic evaluation.
- Current therapeutic modalities present significant financial implications for healthcare systems.
Purpose:
- To critically assess the economic impact of cardiac transplantation and associated bridging therapies.
- To identify key considerations for optimizing the cost-effectiveness and ethical implementation of cardiac replacement strategies.
Summary:
- Cardiac transplantation incurs substantial costs, estimated at 55,000 DM per year of life gained, with limited immediate cost recovery even with high reintegration rates.
- Recommendations include centralizing transplantation in experienced centers, conducting multicenter trials for cost-saving strategies, enhancing professional reintegration programs, and emphasizing ethical considerations.
- Societal input is vital for resource allocation decisions, and a primary preventive approach for coronary artery disease is essential given its role in transplant candidacy.
Impact:
- Highlights the need for specialized centers of excellence for cardiac transplantation to ensure comprehensive patient care and efficient resource utilization.
- Underscores the importance of collaborative multicenter research to develop and validate cost-effective therapeutic strategies in transplantation.
- Emphasizes the ethical imperative and societal responsibility in determining resource allocation for advanced cardiac therapies and the integration of preventive cardiology.